explore
Previous article:
DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article: FDA's Pazdur wants cancer trials to range beyond China alone
Next article: FDA's Pazdur wants cancer trials to range beyond China alone
focus
hotspot
-
Chronically ill young patients struggle to find fertility info
2025-10-01 20:09 -
JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
2025-10-01 20:03 -
ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug
2025-10-01 19:22 -
Woman returns to dialysis after doctors remove transplanted pig kidney
2025-10-01 19:21 -
At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
2025-10-01 19:08 -
3 trends to watch in health tech's hiring outlook for 2024
2025-10-01 18:57